Rank | Gene Set | Z-score |
---|---|---|
1 | Golgi transport vesicle coating (GO:0048200) | 7.23230703 |
2 | COPI coating of Golgi vesicle (GO:0048205) | 7.23230703 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.88100037 |
4 | L-phenylalanine catabolic process (GO:0006559) | 5.88100037 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.67655332 |
6 | L-phenylalanine metabolic process (GO:0006558) | 5.67655332 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 5.24461741 |
8 | alpha-linolenic acid metabolic process (GO:0036109) | 5.02695135 |
9 | cysteine metabolic process (GO:0006534) | 4.96295178 |
10 | glyoxylate metabolic process (GO:0046487) | 4.92844618 |
11 | sulfur amino acid catabolic process (GO:0000098) | 4.82771758 |
12 | lysine metabolic process (GO:0006553) | 4.76947580 |
13 | lysine catabolic process (GO:0006554) | 4.76947580 |
14 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.69789707 |
15 | tryptophan catabolic process (GO:0006569) | 4.68298521 |
16 | indole-containing compound catabolic process (GO:0042436) | 4.68298521 |
17 | indolalkylamine catabolic process (GO:0046218) | 4.68298521 |
18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.63615853 |
19 | kynurenine metabolic process (GO:0070189) | 4.51025298 |
20 | tryptophan metabolic process (GO:0006568) | 4.46174343 |
21 | bile acid biosynthetic process (GO:0006699) | 4.39132967 |
22 | homocysteine metabolic process (GO:0050667) | 4.16738852 |
23 | drug transmembrane transport (GO:0006855) | 4.13646182 |
24 | urea metabolic process (GO:0019627) | 4.13391486 |
25 | urea cycle (GO:0000050) | 4.13391486 |
26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.11251786 |
27 | protein carboxylation (GO:0018214) | 4.11251786 |
28 | high-density lipoprotein particle remodeling (GO:0034375) | 4.05572202 |
29 | COPII vesicle coating (GO:0048208) | 4.03327018 |
30 | amyloid precursor protein catabolic process (GO:0042987) | 4.01151556 |
31 | amino-acid betaine metabolic process (GO:0006577) | 3.99808348 |
32 | urate metabolic process (GO:0046415) | 3.95649346 |
33 | drug catabolic process (GO:0042737) | 3.94295557 |
34 | cellular modified amino acid catabolic process (GO:0042219) | 3.86133424 |
35 | complement activation, alternative pathway (GO:0006957) | 3.85530360 |
36 | serine family amino acid catabolic process (GO:0009071) | 3.81808506 |
37 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.80950266 |
38 | reverse cholesterol transport (GO:0043691) | 3.80817922 |
39 | nitrogen cycle metabolic process (GO:0071941) | 3.80515604 |
40 | bile acid metabolic process (GO:0008206) | 3.79702725 |
41 | aromatic amino acid family metabolic process (GO:0009072) | 3.77519223 |
42 | regulation of triglyceride catabolic process (GO:0010896) | 3.76566680 |
43 | negative regulation of fibrinolysis (GO:0051918) | 3.75919188 |
44 | regulation of cholesterol homeostasis (GO:2000188) | 3.73450625 |
45 | regulation of cholesterol esterification (GO:0010872) | 3.69246004 |
46 | cellular ketone body metabolic process (GO:0046950) | 3.66047997 |
47 | negative regulation of cholesterol transport (GO:0032375) | 3.65513401 |
48 | negative regulation of sterol transport (GO:0032372) | 3.65513401 |
49 | valine metabolic process (GO:0006573) | 3.64379867 |
50 | ethanol oxidation (GO:0006069) | 3.64043961 |
51 | alpha-amino acid catabolic process (GO:1901606) | 3.63311838 |
52 | short-chain fatty acid metabolic process (GO:0046459) | 3.62711510 |
53 | protein-lipid complex remodeling (GO:0034368) | 3.58466489 |
54 | macromolecular complex remodeling (GO:0034367) | 3.58466489 |
55 | plasma lipoprotein particle remodeling (GO:0034369) | 3.58466489 |
56 | plasma lipoprotein particle clearance (GO:0034381) | 3.57853932 |
57 | regulation of protein activation cascade (GO:2000257) | 3.57317895 |
58 | tyrosine metabolic process (GO:0006570) | 3.56448031 |
59 | drug transport (GO:0015893) | 3.56435649 |
60 | phospholipid efflux (GO:0033700) | 3.54897105 |
61 | cellular glucuronidation (GO:0052695) | 3.54517433 |
62 | glutamate metabolic process (GO:0006536) | 3.53193174 |
63 | cellular amino acid catabolic process (GO:0009063) | 3.52635072 |
64 | fatty acid beta-oxidation (GO:0006635) | 3.50526305 |
65 | aspartate family amino acid catabolic process (GO:0009068) | 3.46944487 |
66 | fatty acid oxidation (GO:0019395) | 3.45592923 |
67 | glycosphingolipid catabolic process (GO:0046479) | 3.42298245 |
68 | benzene-containing compound metabolic process (GO:0042537) | 3.41787969 |
69 | lipid oxidation (GO:0034440) | 3.40992228 |
70 | exogenous drug catabolic process (GO:0042738) | 3.39243744 |
71 | regulation of complement activation (GO:0030449) | 3.38670833 |
72 | regulation of fibrinolysis (GO:0051917) | 3.38599775 |
73 | 2-oxoglutarate metabolic process (GO:0006103) | 3.38075979 |
74 | response to mercury ion (GO:0046689) | 3.36453050 |
75 | serine family amino acid metabolic process (GO:0009069) | 3.34176608 |
76 | primary alcohol catabolic process (GO:0034310) | 3.33237105 |
77 | triglyceride homeostasis (GO:0070328) | 3.32839088 |
78 | acylglycerol homeostasis (GO:0055090) | 3.32839088 |
79 | acetyl-CoA metabolic process (GO:0006084) | 3.32452869 |
80 | negative regulation of humoral immune response (GO:0002921) | 3.32321257 |
81 | uronic acid metabolic process (GO:0006063) | 3.32230229 |
82 | glucuronate metabolic process (GO:0019585) | 3.32230229 |
83 | cholesterol efflux (GO:0033344) | 3.31802993 |
84 | indolalkylamine metabolic process (GO:0006586) | 3.29304540 |
85 | aldehyde catabolic process (GO:0046185) | 3.28709951 |
86 | epoxygenase P450 pathway (GO:0019373) | 3.28633323 |
87 | bile acid and bile salt transport (GO:0015721) | 3.28378704 |
88 | flavonoid metabolic process (GO:0009812) | 3.26967226 |
89 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.26259406 |
90 | coenzyme catabolic process (GO:0009109) | 3.25891251 |
91 | fatty acid catabolic process (GO:0009062) | 3.24632508 |
92 | negative regulation of complement activation (GO:0045916) | 3.24615011 |
93 | monocarboxylic acid catabolic process (GO:0072329) | 3.24382499 |
94 | phospholipid homeostasis (GO:0055091) | 3.24091098 |
95 | organic acid catabolic process (GO:0016054) | 3.24079973 |
96 | carboxylic acid catabolic process (GO:0046395) | 3.24079973 |
97 | iron ion import (GO:0097286) | 3.22829046 |
98 | carnitine metabolic process (GO:0009437) | 3.21302075 |
99 | regulation of cholesterol metabolic process (GO:0090181) | 3.20054318 |
100 | glycolipid catabolic process (GO:0019377) | 3.19551278 |
101 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.19484007 |
102 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.19484007 |
103 | ketone body metabolic process (GO:1902224) | 3.19106868 |
104 | serine family amino acid biosynthetic process (GO:0009070) | 3.16429689 |
105 | sphingosine metabolic process (GO:0006670) | 3.15646489 |
106 | negative regulation of protein activation cascade (GO:2000258) | 3.13868087 |
107 | vesicle coating (GO:0006901) | 3.13856943 |
108 | diol metabolic process (GO:0034311) | 3.12860236 |
109 | plasma lipoprotein particle assembly (GO:0034377) | 3.12243876 |
110 | cholesterol homeostasis (GO:0042632) | 3.11527079 |
111 | sterol homeostasis (GO:0055092) | 3.11217119 |
112 | NADH metabolic process (GO:0006734) | 3.09575044 |
113 | cellular biogenic amine catabolic process (GO:0042402) | 3.09512900 |
114 | amine catabolic process (GO:0009310) | 3.09512900 |
115 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.09032455 |
116 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.08848165 |
117 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.08768415 |
118 | tricarboxylic acid metabolic process (GO:0072350) | 3.08587110 |
119 | sphingolipid catabolic process (GO:0030149) | 3.08152396 |
120 | low-density lipoprotein particle remodeling (GO:0034374) | 3.07440017 |
121 | membrane lipid catabolic process (GO:0046466) | 3.04086064 |
122 | intestinal epithelial cell development (GO:0060576) | 3.01279483 |
123 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.99644645 |
124 | L-serine transport (GO:0015825) | 2.99226749 |
125 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.94840031 |
126 | fatty acid elongation (GO:0030497) | 2.91728195 |
127 | ER overload response (GO:0006983) | 2.91377663 |
128 | ethanol metabolic process (GO:0006067) | 2.89525878 |
129 | amyloid precursor protein metabolic process (GO:0042982) | 2.88946730 |
130 | sphingomyelin metabolic process (GO:0006684) | 2.86045968 |
131 | ceramide catabolic process (GO:0046514) | 2.81357037 |
132 | keratan sulfate catabolic process (GO:0042340) | 2.79519574 |
133 | oligosaccharide catabolic process (GO:0009313) | 2.76252423 |
134 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.74862154 |
135 | very long-chain fatty acid metabolic process (GO:0000038) | 2.74610706 |
136 | tricarboxylic acid cycle (GO:0006099) | 2.70966674 |
137 | membrane protein ectodomain proteolysis (GO:0006509) | 2.70200349 |
138 | NADPH regeneration (GO:0006740) | 2.66831681 |
139 | beta-amyloid metabolic process (GO:0050435) | 2.66691759 |
140 | sphingoid metabolic process (GO:0046519) | 2.66570843 |
141 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.65823053 |
142 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.64185485 |
143 | peptide catabolic process (GO:0043171) | 2.60196577 |
144 | serine transport (GO:0032329) | 2.59740428 |
145 | xenobiotic catabolic process (GO:0042178) | 2.58867360 |
146 | desmosome organization (GO:0002934) | 2.56367627 |
147 | proline biosynthetic process (GO:0006561) | 2.54193882 |
148 | branched-chain amino acid catabolic process (GO:0009083) | 2.54087048 |
149 | protein maturation by protein folding (GO:0022417) | 2.53066973 |
150 | glycoside metabolic process (GO:0016137) | 2.52941759 |
151 | regulation of autophagic vacuole assembly (GO:2000785) | 2.50537377 |
152 | protein localization to endosome (GO:0036010) | 2.49034920 |
153 | protein retention in ER lumen (GO:0006621) | 2.46662876 |
154 | cellular copper ion homeostasis (GO:0006878) | 2.46170007 |
155 | primary alcohol metabolic process (GO:0034308) | 2.45270813 |
156 | angiotensin maturation (GO:0002003) | 2.45079397 |
157 | axonemal dynein complex assembly (GO:0070286) | 2.43616369 |
158 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.43437062 |
159 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.42078192 |
160 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.41650122 |
161 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.40536345 |
162 | macroautophagy (GO:0016236) | 2.40314118 |
163 | retinol metabolic process (GO:0042572) | 2.40175693 |
164 | zinc ion transport (GO:0006829) | 2.40063262 |
165 | multicellular organismal water homeostasis (GO:0050891) | 2.39574827 |
166 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.38652551 |
167 | pentose-phosphate shunt (GO:0006098) | 2.38539463 |
168 | regulation of metalloenzyme activity (GO:0048552) | 2.37551369 |
169 | cellular aldehyde metabolic process (GO:0006081) | 2.37547083 |
170 | vitamin transmembrane transport (GO:0035461) | 2.37501654 |
171 | cell adhesion mediated by integrin (GO:0033627) | 2.36479316 |
172 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.34470385 |
173 | retinal metabolic process (GO:0042574) | 2.34292187 |
174 | eosinophil chemotaxis (GO:0048245) | 2.31936047 |
175 | transferrin transport (GO:0033572) | 2.31378084 |
176 | transcytosis (GO:0045056) | 2.30831904 |
177 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.30745386 |
178 | ferric iron transport (GO:0015682) | 2.29540116 |
179 | trivalent inorganic cation transport (GO:0072512) | 2.29540116 |
180 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.29475656 |
181 | regulation of extracellular matrix disassembly (GO:0010715) | 2.29230382 |
182 | regulation of vacuole organization (GO:0044088) | 2.28942903 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.57974385 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.26358344 |
3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.54602117 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.02584666 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.77177193 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.29089481 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.80643388 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.36076237 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.05598367 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.67731422 |
11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.57298369 |
12 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.39904275 |
13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.36300659 |
14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.26996884 |
15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.21021296 |
16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.94323965 |
17 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.87392539 |
18 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.86029400 |
19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.85401854 |
20 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.81924569 |
21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.81535027 |
22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.78095648 |
23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.77297389 |
24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76792618 |
25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75217895 |
26 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.73409939 |
27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.72119032 |
28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.67285762 |
29 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.62754734 |
30 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.60345350 |
31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.55915752 |
32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.55341662 |
33 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55087741 |
34 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.50454843 |
35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49230565 |
36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48043758 |
37 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.47965922 |
38 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.47965922 |
39 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.46747794 |
40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43808723 |
41 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.38128477 |
42 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.37533359 |
43 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.35533024 |
44 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.34671141 |
45 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.32363789 |
46 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.31393693 |
47 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.29048523 |
48 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.28400126 |
49 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.27598550 |
50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25346561 |
51 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.24699687 |
52 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.23891262 |
53 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.23403900 |
54 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23068227 |
55 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.22875829 |
56 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.19079653 |
57 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18361680 |
58 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.18346172 |
59 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16534441 |
60 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16062765 |
61 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16062559 |
62 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15938210 |
63 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.15435428 |
64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13654927 |
65 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.12331965 |
66 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.11052602 |
67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10203177 |
68 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07087529 |
69 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05422776 |
70 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02982758 |
71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.02847592 |
72 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.02296552 |
73 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00422343 |
74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99737963 |
75 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98591314 |
76 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.98532795 |
77 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.98435049 |
78 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.98169339 |
79 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.96696089 |
80 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96109439 |
81 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94906346 |
82 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94811786 |
83 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94446303 |
84 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.94228036 |
85 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93939360 |
86 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.93073909 |
87 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92890457 |
88 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.92385805 |
89 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.91880905 |
90 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.91680658 |
91 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89718760 |
92 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.89662001 |
93 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89243951 |
94 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.88212690 |
95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87829116 |
96 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87098158 |
97 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87039214 |
98 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.86455992 |
99 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.86285404 |
100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85818312 |
101 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85818312 |
102 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83972418 |
103 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82654972 |
104 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.81858432 |
105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.80996828 |
106 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.80955361 |
107 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80213653 |
108 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.79096906 |
109 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.78673304 |
110 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.77220301 |
111 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.76961368 |
112 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.76961368 |
113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.75739474 |
114 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.74357944 |
115 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.74334294 |
116 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74071670 |
117 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73860864 |
118 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.73010115 |
119 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72625397 |
120 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71928782 |
121 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70930195 |
122 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.70483170 |
123 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.70102135 |
124 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.69185053 |
125 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.68059556 |
126 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.67742163 |
127 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.67741986 |
128 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67032924 |
129 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.65610852 |
130 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.65377309 |
131 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.63651907 |
132 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.63268928 |
133 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.63223649 |
134 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.63213943 |
135 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.61995249 |
136 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.61928414 |
137 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61700349 |
138 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.61361164 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 6.58518940 |
2 | MP0002139_abnormal_hepatobiliary_system | 6.54565820 |
3 | MP0005365_abnormal_bile_salt | 4.57944739 |
4 | MP0005085_abnormal_gallbladder_physiolo | 4.53780918 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.17553342 |
6 | MP0003252_abnormal_bile_duct | 3.28283241 |
7 | MP0009840_abnormal_foam_cell | 3.27412592 |
8 | MP0003806_abnormal_nucleotide_metabolis | 3.06854510 |
9 | MP0010329_abnormal_lipoprotein_level | 2.92653750 |
10 | MP0005332_abnormal_amino_acid | 2.88530318 |
11 | MP0003195_calcinosis | 2.78257729 |
12 | MP0003191_abnormal_cellular_cholesterol | 2.70810957 |
13 | MP0001666_abnormal_nutrient_absorption | 2.52583172 |
14 | MP0004019_abnormal_vitamin_homeostasis | 2.46602993 |
15 | MP0002138_abnormal_hepatobiliary_system | 2.39003605 |
16 | MP0009780_abnormal_chondrocyte_physiolo | 2.38023294 |
17 | MP0005083_abnormal_biliary_tract | 2.32657736 |
18 | MP0010678_abnormal_skin_adnexa | 2.19213592 |
19 | MP0009643_abnormal_urine_homeostasis | 2.06464976 |
20 | MP0005058_abnormal_lysosome_morphology | 2.05293879 |
21 | MP0002118_abnormal_lipid_homeostasis | 1.90273785 |
22 | MP0000609_abnormal_liver_physiology | 1.86959477 |
23 | MP0004043_abnormal_pH_regulation | 1.76627862 |
24 | MP0005319_abnormal_enzyme/_coenzyme | 1.70114894 |
25 | MP0010352_gastrointestinal_tract_polyps | 1.59921118 |
26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59317834 |
27 | MP0003300_gastrointestinal_ulcer | 1.59015783 |
28 | MP0002877_abnormal_melanocyte_morpholog | 1.52758456 |
29 | MP0003186_abnormal_redox_activity | 1.48007344 |
30 | MP0003705_abnormal_hypodermis_morpholog | 1.46693886 |
31 | MP0000604_amyloidosis | 1.41964189 |
32 | MP0005248_abnormal_Harderian_gland | 1.40692350 |
33 | MP0001756_abnormal_urination | 1.38629530 |
34 | MP0008260_abnormal_autophagy | 1.38536932 |
35 | MP0002909_abnormal_adrenal_gland | 1.36380826 |
36 | MP0005636_abnormal_mineral_homeostasis | 1.36318548 |
37 | MP0002098_abnormal_vibrissa_morphology | 1.35602492 |
38 | MP0001853_heart_inflammation | 1.33035448 |
39 | MP0001764_abnormal_homeostasis | 1.29382309 |
40 | MP0010234_abnormal_vibrissa_follicle | 1.28377713 |
41 | MP0000383_abnormal_hair_follicle | 1.27676024 |
42 | MP0009764_decreased_sensitivity_to | 1.24018284 |
43 | MP0003724_increased_susceptibility_to | 1.21740205 |
44 | MP0002136_abnormal_kidney_physiology | 1.21219095 |
45 | MP0002090_abnormal_vision | 1.17820272 |
46 | MP0000627_abnormal_mammary_gland | 1.15859768 |
47 | MP0001765_abnormal_ion_homeostasis | 1.12508523 |
48 | MP0003329_amyloid_beta_deposits | 1.11861548 |
49 | MP0004782_abnormal_surfactant_physiolog | 1.11734800 |
50 | MP0003436_decreased_susceptibility_to | 1.11187917 |
51 | MP0002254_reproductive_system_inflammat | 1.10441344 |
52 | MP0008469_abnormal_protein_level | 1.10252243 |
53 | MP0000377_abnormal_hair_follicle | 1.07885027 |
54 | MP0001216_abnormal_epidermal_layer | 1.07366064 |
55 | MP0000858_altered_metastatic_potential | 1.05516725 |
56 | MP0003690_abnormal_glial_cell | 1.05170859 |
57 | MP0000598_abnormal_liver_morphology | 1.04561765 |
58 | MP0005451_abnormal_body_composition | 1.04019782 |
59 | MP0005501_abnormal_skin_physiology | 1.03220768 |
60 | MP0002166_altered_tumor_susceptibility | 1.02493527 |
61 | MP0003868_abnormal_feces_composition | 1.02149336 |
62 | MP0002148_abnormal_hypersensitivity_rea | 1.00557553 |
63 | MP0006082_CNS_inflammation | 1.00109470 |
64 | MP0003656_abnormal_erythrocyte_physiolo | 0.99777791 |
65 | MP0002132_abnormal_respiratory_system | 0.98351478 |
66 | MP0005310_abnormal_salivary_gland | 0.97986433 |
67 | MP0005167_abnormal_blood-brain_barrier | 0.96595238 |
68 | MP0005670_abnormal_white_adipose | 0.96271648 |
69 | MP0001727_abnormal_embryo_implantation | 0.95497358 |
70 | * MP0005165_increased_susceptibility_to | 0.93775631 |
71 | MP0005408_hypopigmentation | 0.91269001 |
72 | MP0003011_delayed_dark_adaptation | 0.89847483 |
73 | MP0005464_abnormal_platelet_physiology | 0.89781444 |
74 | MP0003172_abnormal_lysosome_physiology | 0.89662843 |
75 | MP0009642_abnormal_blood_homeostasis | 0.89319893 |
76 | MP0001958_emphysema | 0.87203190 |
77 | MP0003941_abnormal_skin_development | 0.86854786 |
78 | MP0009763_increased_sensitivity_to | 0.86578086 |
79 | MP0004264_abnormal_extraembryonic_tissu | 0.85172913 |
80 | MP0003866_abnormal_defecation | 0.84620209 |
81 | MP0001873_stomach_inflammation | 0.82300932 |
82 | MP0005379_endocrine/exocrine_gland_phen | 0.79812646 |
83 | MP0004130_abnormal_muscle_cell | 0.79730511 |
84 | MP0005084_abnormal_gallbladder_morpholo | 0.79582011 |
85 | MP0005220_abnormal_exocrine_pancreas | 0.79545290 |
86 | MP0000427_abnormal_hair_cycle | 0.78983796 |
87 | * MP0003075_altered_response_to | 0.78290407 |
88 | MP0002078_abnormal_glucose_homeostasis | 0.77879650 |
89 | MP0002876_abnormal_thyroid_physiology | 0.77727809 |
90 | MP0002896_abnormal_bone_mineralization | 0.75953800 |
91 | MP0004947_skin_inflammation | 0.75952917 |
92 | MP0001845_abnormal_inflammatory_respons | 0.74985303 |
93 | MP0000516_abnormal_urinary_system | 0.74684896 |
94 | MP0005367_renal/urinary_system_phenotyp | 0.74684896 |
95 | MP0000920_abnormal_myelination | 0.74401082 |
96 | MP0003448_altered_tumor_morphology | 0.74284000 |
97 | MP0010368_abnormal_lymphatic_system | 0.73979683 |
98 | MP0003183_abnormal_peptide_metabolism | 0.73461842 |
99 | MP0004883_abnormal_blood_vessel | 0.73050426 |
100 | MP0005647_abnormal_sex_gland | 0.72831478 |
101 | MP0004272_abnormal_basement_membrane | 0.72711456 |
102 | MP0002971_abnormal_brown_adipose | 0.72198525 |
103 | MP0005166_decreased_susceptibility_to | 0.71709217 |
104 | MP0001533_abnormal_skeleton_physiology | 0.71437682 |
105 | MP0005535_abnormal_body_temperature | 0.69401384 |
106 | MP0002419_abnormal_innate_immunity | 0.69164188 |
107 | MP0009785_altered_susceptibility_to | 0.68390967 |
108 | MP0002168_other_aberrant_phenotype | 0.67890474 |
109 | MP0005666_abnormal_adipose_tissue | 0.67525569 |
110 | MP0003303_peritoneal_inflammation | 0.67100824 |
111 | MP0009765_abnormal_xenobiotic_induced | 0.66298366 |
112 | MP0001835_abnormal_antigen_presentation | 0.66176577 |
113 | MP0005376_homeostasis/metabolism_phenot | 0.63332952 |
114 | MP0003638_abnormal_response/metabolism_ | 0.62792899 |
115 | MP0005334_abnormal_fat_pad | 0.62381722 |
116 | MP0002928_abnormal_bile_duct | 0.62167023 |
117 | MP0005025_abnormal_response_to | 0.61226376 |
118 | MP0008438_abnormal_cutaneous_collagen | 0.60537080 |
119 | MP0002796_impaired_skin_barrier | 0.58736486 |
120 | MP0006036_abnormal_mitochondrial_physio | 0.58639537 |
121 | MP0010155_abnormal_intestine_physiology | 0.58503410 |
122 | MP0002135_abnormal_kidney_morphology | 0.56637275 |
123 | MP0000685_abnormal_immune_system | 0.56417426 |
124 | MP0000249_abnormal_blood_vessel | 0.56263705 |
125 | MP0003453_abnormal_keratinocyte_physiol | 0.55620002 |
126 | MP0006054_spinal_hemorrhage | 0.55394087 |
127 | MP0003566_abnormal_cell_adhesion | 0.55140936 |
128 | MP0001881_abnormal_mammary_gland | 0.55062321 |
129 | MP0005023_abnormal_wound_healing | 0.55042488 |
130 | MP0009384_cardiac_valve_regurgitation | 0.54711375 |
131 | MP0005164_abnormal_response_to | 0.53904641 |
132 | MP0000230_abnormal_systemic_arterial | 0.53327750 |
133 | MP0000343_altered_response_to | 0.52026791 |
134 | MP0002295_abnormal_pulmonary_circulatio | 0.51751188 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.36562813 |
2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.13543682 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.13543682 |
4 | Abnormality of glycolipid metabolism (HP:0010969) | 5.13543682 |
5 | Deep venous thrombosis (HP:0002625) | 5.05962427 |
6 | Intrahepatic cholestasis (HP:0001406) | 5.01549325 |
7 | Xanthomatosis (HP:0000991) | 4.95577590 |
8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.68022063 |
9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.43417451 |
10 | Hyperglycinuria (HP:0003108) | 4.00539363 |
11 | Hypobetalipoproteinemia (HP:0003563) | 3.97867382 |
12 | Gout (HP:0001997) | 3.92613746 |
13 | Ketosis (HP:0001946) | 3.85404063 |
14 | Complement deficiency (HP:0004431) | 3.84372271 |
15 | Loss of speech (HP:0002371) | 3.77778601 |
16 | Prolonged partial thromboplastin time (HP:0003645) | 3.76278268 |
17 | Hyperammonemia (HP:0001987) | 3.71328304 |
18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.69340483 |
19 | Abnormality of glycine metabolism (HP:0010895) | 3.69340483 |
20 | Hyperlipoproteinemia (HP:0010980) | 3.67255934 |
21 | Abnormality of purine metabolism (HP:0004352) | 3.48389255 |
22 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.47256277 |
23 | Hypoglycemic coma (HP:0001325) | 3.45116650 |
24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.42209269 |
25 | Joint hemorrhage (HP:0005261) | 3.38045899 |
26 | Ketoacidosis (HP:0001993) | 3.37497441 |
27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.35863371 |
28 | Hypokinesia (HP:0002375) | 3.35004229 |
29 | Fat malabsorption (HP:0002630) | 3.24597282 |
30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.24238569 |
31 | Hyperglycinemia (HP:0002154) | 3.21434035 |
32 | Hypolipoproteinemia (HP:0010981) | 3.10638085 |
33 | Epidermoid cyst (HP:0200040) | 3.07708304 |
34 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.05694826 |
35 | Abnormality of nucleobase metabolism (HP:0010932) | 3.03953330 |
36 | Systemic lupus erythematosus (HP:0002725) | 2.96403994 |
37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.91872032 |
38 | Rhinitis (HP:0012384) | 2.86887874 |
39 | Abnormality of the intrinsic pathway (HP:0010989) | 2.86325995 |
40 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.86123676 |
41 | Hyperactive renin-angiotensin system (HP:0000841) | 2.84801647 |
42 | Abnormality of complement system (HP:0005339) | 2.84639033 |
43 | Vascular calcification (HP:0004934) | 2.84507336 |
44 | Generalized aminoaciduria (HP:0002909) | 2.83383702 |
45 | Abnormality of proline metabolism (HP:0010907) | 2.83306737 |
46 | Hydroxyprolinuria (HP:0003080) | 2.83306737 |
47 | Alkalosis (HP:0001948) | 2.81430776 |
48 | Increased cerebral lipofuscin (HP:0011813) | 2.80861366 |
49 | Hypoalphalipoproteinemia (HP:0003233) | 2.80694122 |
50 | Hypokalemic alkalosis (HP:0001949) | 2.74321811 |
51 | Increased CSF protein (HP:0002922) | 2.71152504 |
52 | Vacuolated lymphocytes (HP:0001922) | 2.65127296 |
53 | Hyperuricemia (HP:0002149) | 2.63156341 |
54 | Increased purine levels (HP:0004368) | 2.63156341 |
55 | Myocardial infarction (HP:0001658) | 2.62755556 |
56 | Progressive neurologic deterioration (HP:0002344) | 2.61763646 |
57 | Hypercholesterolemia (HP:0003124) | 2.61138638 |
58 | Proximal tubulopathy (HP:0000114) | 2.60310604 |
59 | Cardiovascular calcification (HP:0011915) | 2.57373390 |
60 | Conjugated hyperbilirubinemia (HP:0002908) | 2.55153153 |
61 | Abnormality of methionine metabolism (HP:0010901) | 2.53878455 |
62 | Abnormal gallbladder physiology (HP:0012438) | 2.53620809 |
63 | Cholecystitis (HP:0001082) | 2.53620809 |
64 | Delayed CNS myelination (HP:0002188) | 2.51252200 |
65 | Abnormality of macrophages (HP:0004311) | 2.49491981 |
66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46933312 |
67 | Steatorrhea (HP:0002570) | 2.44763631 |
68 | Metabolic acidosis (HP:0001942) | 2.44530551 |
69 | Hyperbilirubinemia (HP:0002904) | 2.44300611 |
70 | Nuclear cataract (HP:0100018) | 2.43060575 |
71 | Malnutrition (HP:0004395) | 2.42881641 |
72 | Hepatocellular carcinoma (HP:0001402) | 2.41590091 |
73 | Right ventricular cardiomyopathy (HP:0011663) | 2.40816951 |
74 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.37872046 |
75 | Mucopolysacchariduria (HP:0008155) | 2.37872046 |
76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.37252298 |
77 | Dicarboxylic aciduria (HP:0003215) | 2.37252298 |
78 | Sensorimotor neuropathy (HP:0007141) | 2.34546971 |
79 | Abnormality of chloride homeostasis (HP:0011422) | 2.33798490 |
80 | Esophageal varix (HP:0002040) | 2.33229785 |
81 | Dysostosis multiplex (HP:0000943) | 2.32058868 |
82 | Osteolytic defects of the hand bones (HP:0009699) | 2.31223559 |
83 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.31223559 |
84 | Amyloidosis (HP:0011034) | 2.30299889 |
85 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.30212198 |
86 | Vertebral compression fractures (HP:0002953) | 2.29262543 |
87 | Cardiomegaly (HP:0001640) | 2.29237668 |
88 | Metabolic alkalosis (HP:0200114) | 2.27343425 |
89 | Spastic diplegia (HP:0001264) | 2.26384418 |
90 | Irritability (HP:0000737) | 2.24749853 |
91 | Late onset (HP:0003584) | 2.20250644 |
92 | Mitral stenosis (HP:0001718) | 2.20196987 |
93 | Glomerulonephritis (HP:0000099) | 2.19440383 |
94 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.17021987 |
95 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.17021987 |
96 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.17021987 |
97 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.16145814 |
98 | Hypoglycemic seizures (HP:0002173) | 2.15254876 |
99 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.15081478 |
100 | Increased circulating renin level (HP:0000848) | 2.14423230 |
101 | Skin nodule (HP:0200036) | 2.14338157 |
102 | Axonal loss (HP:0003447) | 2.14054433 |
103 | Pancreatitis (HP:0001733) | 2.13633646 |
104 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.13580284 |
105 | J-shaped sella turcica (HP:0002680) | 2.10971836 |
106 | Chronic bronchitis (HP:0004469) | 2.10822552 |
107 | Micronodular cirrhosis (HP:0001413) | 2.10773193 |
108 | Neurofibrillary tangles (HP:0002185) | 2.09904013 |
109 | Hepatosplenomegaly (HP:0001433) | 2.08769578 |
110 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.06664459 |
111 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.06664459 |
112 | Prolonged neonatal jaundice (HP:0006579) | 2.04637928 |
113 | Abnormal urine output (HP:0012590) | 2.04509316 |
114 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.04274574 |
115 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.03313089 |
116 | Short nail (HP:0001799) | 2.03192119 |
117 | Interstitial pulmonary disease (HP:0006530) | 2.02171888 |
118 | Vomiting (HP:0002013) | 1.99602608 |
119 | Abnormality of renal excretion (HP:0011036) | 1.99332907 |
120 | Nephrolithiasis (HP:0000787) | 1.99264030 |
121 | Lethargy (HP:0001254) | 1.99117006 |
122 | Glycosuria (HP:0003076) | 1.99076074 |
123 | Abnormality of urine glucose concentration (HP:0011016) | 1.99076074 |
124 | Tetraparesis (HP:0002273) | 1.98910651 |
125 | Abnormality of serum amino acid levels (HP:0003112) | 1.98511800 |
126 | Hypotension (HP:0002615) | 1.98000744 |
127 | Protuberant abdomen (HP:0001538) | 1.97747266 |
128 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.97623726 |
129 | Bronchiectasis (HP:0002110) | 1.96969593 |
130 | Hemorrhage of the eye (HP:0011885) | 1.93548660 |
131 | Abdominal distention (HP:0003270) | 1.93329529 |
132 | Rickets (HP:0002748) | 1.92572323 |
133 | Elevated alkaline phosphatase (HP:0003155) | 1.90070434 |
134 | Abnormality of vitamin metabolism (HP:0100508) | 1.89815186 |
135 | Nephritis (HP:0000123) | 1.89739907 |
136 | Symptomatic seizures (HP:0011145) | 1.89468955 |
137 | Neonatal onset (HP:0003623) | 1.89016289 |
138 | Abnormal gallbladder morphology (HP:0012437) | 1.88109930 |
139 | Beaking of vertebral bodies (HP:0004568) | 1.87808424 |
140 | Renal salt wasting (HP:0000127) | 1.87403535 |
141 | Abnormal ciliary motility (HP:0012262) | 1.86645962 |
142 | Pili torti (HP:0003777) | 1.82773233 |
143 | Abnormality of glycolysis (HP:0004366) | 1.81512253 |
144 | Chronic diarrhea (HP:0002028) | 1.81105141 |
145 | Lower limb hyperreflexia (HP:0002395) | 1.80144345 |
146 | Degeneration of anterior horn cells (HP:0002398) | 1.79397560 |
147 | Abnormality of the anterior horn cell (HP:0006802) | 1.79397560 |
148 | Diminished movement (HP:0002374) | 1.76904599 |
149 | Glucose intolerance (HP:0000833) | 1.76640772 |
150 | Abnormal glucose tolerance (HP:0001952) | 1.76238164 |
151 | Bone pain (HP:0002653) | 1.75986689 |
152 | Autoamputation (HP:0001218) | 1.75845450 |
153 | Nasal polyposis (HP:0100582) | 1.73660553 |
154 | Type I transferrin isoform profile (HP:0003642) | 1.70355069 |
155 | Spastic paraparesis (HP:0002313) | 1.66396428 |
156 | Growth hormone excess (HP:0000845) | 1.66120920 |
157 | Tongue fasciculations (HP:0001308) | 1.65359775 |
158 | Cholelithiasis (HP:0001081) | 1.64665829 |
159 | Increased serum pyruvate (HP:0003542) | 1.64555703 |
160 | Flat acetabular roof (HP:0003180) | 1.64071731 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 4.89284475 |
2 | BCKDK | 4.25273898 |
3 | EIF2AK1 | 3.75983605 |
4 | MAP3K12 | 3.49503406 |
5 | SIK1 | 3.24691077 |
6 | TRIB3 | 3.15830878 |
7 | FGFR4 | 3.06523376 |
8 | SCYL2 | 2.67997722 |
9 | EIF2AK3 | 2.50312010 |
10 | WNK4 | 2.48466835 |
11 | EPHB1 | 2.39540111 |
12 | TAOK3 | 2.29657917 |
13 | MST1R | 2.10818264 |
14 | PBK | 1.95789906 |
15 | PKN2 | 1.88801651 |
16 | PTK6 | 1.87499358 |
17 | OXSR1 | 1.82258989 |
18 | TYK2 | 1.70510116 |
19 | TBK1 | 1.64236791 |
20 | FRK | 1.60394790 |
21 | SIK3 | 1.58690231 |
22 | NEK6 | 1.57848175 |
23 | TGFBR2 | 1.57758090 |
24 | LIMK1 | 1.57645299 |
25 | MAPKAPK3 | 1.56250572 |
26 | WNK3 | 1.53591438 |
27 | INSRR | 1.52292836 |
28 | LRRK2 | 1.47047388 |
29 | TSSK6 | 1.44674670 |
30 | RIPK1 | 1.43496235 |
31 | JAK1 | 1.41963928 |
32 | BMPR2 | 1.35051705 |
33 | MAP4K1 | 1.24016197 |
34 | NEK1 | 1.19803028 |
35 | YES1 | 1.18715496 |
36 | TRIM28 | 1.17609952 |
37 | ERBB3 | 1.17248735 |
38 | MET | 1.16415345 |
39 | MAPK15 | 1.15309154 |
40 | STK39 | 1.14327102 |
41 | MAP3K14 | 1.12984072 |
42 | JAK2 | 1.10040483 |
43 | MST4 | 1.09474433 |
44 | ZAP70 | 1.08411307 |
45 | CSK | 1.08066051 |
46 | NEK9 | 1.07576502 |
47 | STK10 | 1.06942977 |
48 | KDR | 1.06419088 |
49 | ERBB4 | 1.06013698 |
50 | MAP3K3 | 1.04195142 |
51 | PTK2 | 1.03544689 |
52 | MAP3K2 | 1.02998963 |
53 | GRK6 | 1.01759517 |
54 | FLT3 | 1.01198545 |
55 | TTK | 1.00976612 |
56 | PIK3CG | 0.97689528 |
57 | BCR | 0.97311122 |
58 | EPHA3 | 0.95656344 |
59 | IKBKE | 0.92688995 |
60 | MAP2K3 | 0.91280027 |
61 | LMTK2 | 0.91199142 |
62 | MAPK11 | 0.90874519 |
63 | IRAK3 | 0.88553360 |
64 | LATS1 | 0.88341889 |
65 | TIE1 | 0.87886990 |
66 | BMX | 0.87564155 |
67 | JAK3 | 0.85598354 |
68 | TESK1 | 0.85199032 |
69 | PDK2 | 0.78826016 |
70 | SGK3 | 0.78484412 |
71 | BLK | 0.76293058 |
72 | PDPK1 | 0.75974564 |
73 | PAK4 | 0.75628321 |
74 | PRKCI | 0.75231831 |
75 | CAMK1D | 0.73708440 |
76 | MAP3K7 | 0.73584015 |
77 | FGFR3 | 0.72831750 |
78 | FGFR2 | 0.72487003 |
79 | GSK3A | 0.70088248 |
80 | PDGFRA | 0.69621304 |
81 | ABL2 | 0.67326080 |
82 | SGK494 | 0.67267842 |
83 | SGK223 | 0.67267842 |
84 | EPHA2 | 0.67099837 |
85 | PIM2 | 0.66887176 |
86 | ROCK2 | 0.66768415 |
87 | MAP2K2 | 0.66293102 |
88 | CSF1R | 0.66032112 |
89 | MAP3K10 | 0.65885145 |
90 | BRSK2 | 0.65834903 |
91 | ITK | 0.64706450 |
92 | FER | 0.62666921 |
93 | MYLK | 0.58998907 |
94 | DYRK1B | 0.58522462 |
95 | SMG1 | 0.56779937 |
96 | EEF2K | 0.56685724 |
97 | PRKAA2 | 0.56533385 |
98 | MAP3K1 | 0.56271158 |
99 | PRKG2 | 0.55954237 |
100 | MAPKAPK2 | 0.54716616 |
101 | PRKCH | 0.54274716 |
102 | KIT | 0.53659346 |
103 | KSR2 | 0.51919464 |
104 | TAOK1 | 0.51567041 |
105 | BTK | 0.50345123 |
106 | STK38L | 0.50272473 |
107 | PDK1 | 0.50159771 |
108 | TTN | 0.49039966 |
109 | RET | 0.48190247 |
110 | PRKCZ | 0.47774935 |
111 | DAPK1 | 0.46479231 |
112 | DAPK2 | 0.46221046 |
113 | CAMK2G | 0.46112504 |
114 | CDK6 | 0.45551653 |
115 | MAP2K1 | 0.44860670 |
116 | TESK2 | 0.44057625 |
117 | CAMK2D | 0.43993143 |
118 | ILK | 0.43206587 |
119 | PRKCQ | 0.43072880 |
120 | PRKACG | 0.41520526 |
121 | ERBB2 | 0.41082115 |
122 | CHUK | 0.41006997 |
123 | MATK | 0.40610428 |
124 | PDK4 | 0.40182347 |
125 | PDK3 | 0.40182347 |
126 | FGR | 0.40020274 |
127 | NTRK1 | 0.39854414 |
128 | IGF1R | 0.39684488 |
129 | ARAF | 0.39467769 |
130 | STK24 | 0.38582013 |
131 | MAP3K11 | 0.37411368 |
132 | CLK1 | 0.35346006 |
133 | AKT2 | 0.32185263 |
134 | TXK | 0.31586556 |
135 | BRSK1 | 0.31213262 |
136 | IRAK1 | 0.31131736 |
137 | TRPM7 | 0.28864259 |
138 | MAP3K8 | 0.28066388 |
139 | SRC | 0.27735917 |
140 | TAOK2 | 0.27515279 |
141 | ABL1 | 0.26257268 |
142 | NME2 | 0.25934025 |
143 | PRKCE | 0.25795306 |
144 | STK38 | 0.25286684 |
145 | PRKD3 | 0.24534328 |
146 | SRPK1 | 0.24183797 |
147 | EGFR | 0.22947905 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.39842335 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34751020 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.25819511 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.68769278 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.60554721 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.56185772 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.53335838 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.49079437 |
9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.46790520 |
10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.45745935 |
11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.43688233 |
12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.21899269 |
13 | Peroxisome_Homo sapiens_hsa04146 | 2.09075690 |
14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.06299689 |
15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.06280267 |
16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.05293904 |
17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.98670887 |
18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.95925189 |
19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90576881 |
20 | Proteasome_Homo sapiens_hsa03050 | 1.90405775 |
21 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.89986354 |
22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.89314972 |
23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86666876 |
24 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.78580855 |
25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.75837761 |
26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75155706 |
27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70445213 |
28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.64611717 |
29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.64402016 |
30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64112894 |
31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.63691110 |
32 | Bile secretion_Homo sapiens_hsa04976 | 1.59865641 |
33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49886324 |
34 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.49567909 |
35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.48472317 |
36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47519077 |
37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41596365 |
38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.40558901 |
39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.38059706 |
40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.31095968 |
41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.29353517 |
42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27733108 |
43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.25286697 |
44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.25108638 |
45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.24421335 |
46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.24336986 |
47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20950771 |
48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.20640222 |
49 | Protein export_Homo sapiens_hsa03060 | 1.18358664 |
50 | ABC transporters_Homo sapiens_hsa02010 | 1.17585873 |
51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.17434244 |
52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13028778 |
53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.05231982 |
54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.03236526 |
55 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.02482839 |
56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.01201875 |
57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00817282 |
58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97118963 |
59 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.93454149 |
60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92156311 |
61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.90493101 |
62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88317630 |
63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.87156621 |
64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.85661968 |
65 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.84238742 |
66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83549571 |
67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83110015 |
68 | Lysosome_Homo sapiens_hsa04142 | 0.75039649 |
69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74386367 |
70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73455194 |
71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73335939 |
72 | Lysine degradation_Homo sapiens_hsa00310 | 0.72843273 |
73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72727354 |
74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72681142 |
75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67478481 |
76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65022654 |
77 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65013826 |
78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63170102 |
79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60648911 |
80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59646216 |
81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54407065 |
82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51487513 |
83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50083519 |
84 | Mineral absorption_Homo sapiens_hsa04978 | 0.49081390 |
85 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45186244 |
86 | Insulin resistance_Homo sapiens_hsa04931 | 0.44478390 |
87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42423871 |
88 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.42100314 |
89 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.41392259 |
90 | Salmonella infection_Homo sapiens_hsa05132 | 0.40476089 |
91 | Shigellosis_Homo sapiens_hsa05131 | 0.39514075 |
92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37360146 |
93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33966868 |
94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.31729809 |
95 | Endocytosis_Homo sapiens_hsa04144 | 0.29853803 |
96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29320273 |
97 | Prion diseases_Homo sapiens_hsa05020 | 0.28261366 |
98 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.25866034 |
99 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.23786545 |
100 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23657160 |
101 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.23148453 |
102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22903899 |
103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.16926758 |
104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.16560457 |
105 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.13551494 |
106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11444420 |
107 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11317902 |
108 | Hepatitis C_Homo sapiens_hsa05160 | 0.11201073 |
109 | Pertussis_Homo sapiens_hsa05133 | 0.10360083 |
110 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.09503267 |
111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05922075 |
112 | Amoebiasis_Homo sapiens_hsa05146 | 0.05147642 |
113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.05139687 |
114 | Legionellosis_Homo sapiens_hsa05134 | 0.04769482 |
115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.02743669 |
116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.02337241 |
117 | Leishmaniasis_Homo sapiens_hsa05140 | 0.02010811 |
118 | Phagosome_Homo sapiens_hsa04145 | 0.01924829 |
119 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.00368230 |
120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0292827 |
121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0049120 |